Business
Ocumetics Technology Announces Amendment to Brokered LIFE Offering Led by Centurion One Capital
(TheNewswire)   Calgary, AB – TheNewswire - December 19, 2025 – Ocum...
About this update from Ocumetics Technology Corp
[{"type":"text","content":"Ocumetics Technology Announces Amendment to Brokered LIFE Offering Led by Centurion One Capital\n(TheNewswire)\n\n\n \n\n\n\n\n\nCalgary, AB – TheNewswire - December 19, 2025 – Ocumetics Technology Corp. (“Ocumetics” or the\n“Corporation”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QB0) announces that further to its previously announced (November\n25, 2025) brokered private placement (the “Offering”) on a\nbest-efforts basis led by Centurion One Capital Corp. (the\n“Lead Agent”), the Corporation has amended the\nterms of the Offering. \n\n\n \n\n\nPursuant to the amended terms, up to 4,166,666 units of\nthe Corporation (“Units”) will now be issued at an amended\nissue price of $0.60 per Unit (the “Amended Issue Price”) for aggregate gross proceeds of up to $2,500,000. Each\nUnit shall consist of one common share in the capital of the\nCorporation (each, a “Share”) and one common share purchase\nwarrant (each, a “Warrant”). Each\nWarrant will entitle the holder thereof to acquire one common share of\nthe Corporation (each, a “Warrant Share”) at an exercise price of\n$0.75 per Warrant Share at any time for a period of three (3) years\nfollowing the Closing Date (as defined herein).\n\n\n \n\n\nIn addition, the Corporation will now grant the Lead\nAgent an option to sell up to an additional 625,000 Units at the\nAmended Issue Price for additional gross proceeds of up to $375,000\n(the “Agent’s\nOption”) on the same terms and conditions as\nset out herein. The Agent’s Option is exercisable in whole or in\npart at any time up to two business days prior to the Closing Date.\n\n\n\n \n\n\nThe gross proceeds of the Offering are expected to be\nused to fund the Corporation’s first-in-human clinical trials, for\nongoing research and development and for general corporate purposes.\n Although the Corporation intends to use the proceeds of the offering\nas described above, the actual allocation of proceeds may vary from\nthe uses set out above, depending upon future operations, events or\nopportunities.\n\n\n \n\n\nThe Units will be offered for sale (i) by way of\nprivate placement pursuant to the listed issuer financing exemption\nunder section 5A....